[Regional radiotherapy with chemotherapy (VMB) compared to subtotal-nodal irradiation. A Stanford study].
Busch
M
M
Dühmke
E
E
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008198:Lymph Nodes / Q000528:radiation effects; D008727:Methotrexate / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D014747:Vinblastine / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D001761:Bleomycin; D014747:Vinblastine; D008727:Methotrexate
Regionale Radiotherapie mit Chemotherapie (VMB) im Vergleich zur subtotal-nodalen Bestrahlung--Eine Stanford-Studie.